Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
93
天
APOBEC Status Classification Using a Curated Gene Panel in Multiple Myeloma
作者
Dimitris Vraxnos; Paris Vogazianos; Cameron Brown; Marta Lionetti; Juan Carlos Entizne; Emily Charalambous; Athos Antoniades; Niccolo Bolli展开收起
作者单位
1. Stremble Ventures LTD Germasogeia Limassol Cyprus; 2. Department of Oncology and Hemato‐Oncology University of Milan Milan Italy; 3. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy展开收起
9
天
Characterization of Adverse Cutaneous Effects in the Setting of Ponatinib, Bosutinib, and Asciminib for Chronic Myeloid Leukemia Patients
作者
Ruhi Kanwar; Juna Khang; Goranit Sakunchotpanit; Ruhi Nayak; Nicole R. LeBoeuf; Vinod E. Nambudiri展开收起
作者单位
1. Department of Medicine Brigham and Women's Hospital Boston Massachusetts USA; 2. Harvard Medical School Boston Massachusetts USA; 3. Cutaneous Oncology Program Dana‐Farber Cancer Institute Boston Massachusetts USA; 4. Department of Dermatology Brigham and Women's Hospital Boston Massachusetts USA; 5. Department of Dermatology, NYU Grossman School of Medicine New York USA展开收起
257
天
Teclistamab Induced a Profound Hematologic Response in Light Chain Deposition Disease With Probable Cardiac Involvement
作者
Xinyi Xiong; Danqing Zhao; Jian Li; Kaini Shen展开收起
作者单位
1. Department of Hematology Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China; 2. Center for Rare Diseases State Key Laboratory of Complex, Severe, and Rare Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China展开收起
204
天
Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis
作者
Sohaib Irfan; Harshit Khosla; Saad Nasir; Manmeet Kaur; Tyler J. Varisco; Onyebuchi Ononogbu; Sharda Singh; Muhammad Bilal Abid展开收起
作者单位
1. The Aga Khan University School of Medicine Karachi Pakistan; 2. Department of Hematology/Oncology The University of Texas Houston McGovern School of Medicine Houston Texas USA; 3. Department of Lymphoma/Myeloma MD Anderson Cancer Center Houston Texas USA; 4. Center for Learning Health System Sciences University of Minnesota Minneapolis Minnesota USA; 5. University of Texas at Austin College of Pharmacy Austin Texas USA; 6. University of Houston College of Pharmacy Houston Texas USA; 7. Hematology and Medical Oncology Texas Tech University Health Sciences Center, School of Medicine Lubbock Texas USA展开收起
63
天
Age‐Stratified Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes: A Comprehensive Review
作者
Ning Wu; Meng Lv; Xiao‐Dong Mo; Yu‐Qian Sun; Yi‐Fei Cheng; Lan‐Ping Xu; Xiao‐Hui Zhang; Xiao‐Jun Huang; Yu Wang展开收起
作者单位
1. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies Peking University People's Hospital Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Peking University Beijing China; 2. Peking‐Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing China; 3. State Key Laboratory of Natural and Biomimetic Drugs Peking University Beijing China展开收起
164
天
The Germline SH2B3 rs111340708 Splicing Variant Drives Intron Retention and Protein Instability by Impacting Clinical Outcomes in Core Binding Factor AML
作者
Marta Rachele Stefanucci; Livia Leuzzi; Linda Montavoci; Davide Paolo Bernasconi; Luca Cimaschi; Alessandra Trojani; Anna Caretti; Lorenzo Del Castello; Roberto Cairoli; Alessandro Beghini展开收起
作者单位
1. Department of Health Sciences University of Milano Milano Italy; 2. Department of Hematology and Oncology ASST Grande Ospedale Metropolitano Niguarda Milano Italy; 3. UOC of Hematology ASST Fatebenefratelli Sacco Milano Italy; 4. Bicocca Bioinformatics Biostatistics and Bioimaging Centre University of Milano‐Bicocca Milano Italy展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
